| 2026-08-13 | Press release | Serina Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates |
| 2026-07-24 | Press release | Serina Therapeutics to Participate in the BTIG Virtual Biotechnology Conference |
| 2026-07-23 | Press release | Serina Therapeutics Announces Completion of Enrollment and Dosing in Cohort 1 of Registrational Trial of SER-252 for Adv |
| 2026-07-22 | Press release | Serina Therapeutics Appoints Farrell Simon to its Board of Directors |
| 2026-07-07 | Press release | Serina Therapeutics Announces Completion of Sentinel Dosing in Cohort 1 of Phase 1b Registrational Trial of SER-252 for |
| 2026-05-22 | Press release | Enable Injections Announces CE Certification of the enFuse® On-Body Delivery System for Use with Aspaveli® Distributed b |
| 2026-04-07 | Press release | Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit |
| 2026-04-02 | Press release | Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan |
| 2026-03-25 | Press release | Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights |
| 2026-03-24 | Press release | Serina Therapeutics to Present at the 38th Annual Roth Conference |
| 2026-03-18 | Press release | Serina Therapeutics Secures up to $30 Million in Private Placement to Advance Registrational Trial of SER-252 for Advanc |
| 2026-02-24 | Press release | Serina Therapeutics Announces Dosing of First Patient in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson |
| 2026-02-19 | Press release | Serina Therapeutics Announces First Patient Enrolled in Phase 1b Registrational Trial of SER-252 for Advanced Parkinson' |
| 2026-02-03 | Press release | Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event |
| 2026-01-29 | Press release | Serina Therapeutics Announces FDA Clearance of IND Application for SER-252 for the Treatment of Advanced Parkinson’s dis |
| 2026-01-15 | Press release | Serina Therapeutics Receives NYSE Deficiency Notification Regarding Shareholders' Equity |
| 2026-01-06 | Press release | Enable Injections Announces $30 Million Investment from Sanofi to Accelerate Manufacturing Capabilities |
| 2025-12-18 | Press release | Enable Injections Announces Regulatory Approval in Saudi Arabia for the EMPAVELI® Injector based on enFuse® Technology |
| 2025-12-11 | Press release | Serina Therapeutics Strengthens Leadership Team with Appointment of Dr. Joshua Thomas as VP, Head of Chemistry |
| 2025-12-10 | Press release | Serina Therapeutics Submits Complete Response to FDA Clinical Hold Letter for SER-252 Program |
| 2025-11-03 | Press release | Serina Therapeutics Provides Regulatory Update on SER-252 Program |
| 2025-10-08 | Press release | Serina Therapeutics Launches Enhanced Corporate Communications Platform to Strengthen Engagement with Patients, Clinicia |
| 2025-10-06 | Press release | Serina Therapeutics Draws First $5 Million Funding Tranche to Support Registrational Trial of SER-252 in Parkinson’s Dis |
| 2025-09-09 | Press release | Serina Therapeutics Secures Up to $20 Million to Advance Registrational Trial of SER-252 in Parkinson’s Disease |
| 2025-09-08 | Press release | Serina Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference |
| 2025-08-25 | Press release | Serina Therapeutics Announces FDA Feedback Supports Registrational Trial Design of SER-252 in Advanced Parkinson’s Disea |
| 2025-08-12 | Press release | Enable Injections Announces enFuse® System Regulatory Approval in Brazil and MRHA Medical Device Registration in the UK |
| 2025-07-29 | Press release | Serina Therapeutics Advances POZ-VMAT2i into Development for Tardive Dyskinesia (TD) |
| 2025-07-28 | Press release | Serina Therapeutics to Present at the BTIG Virtual Biotechnology Conference |
| 2025-07-10 | Press release | Serina Therapeutics Makes Grant to New Employee Under Inducement Plan |
| 2025-07-01 | Press release | Serina Therapeutics Announces Date for 2025 Annual Stockholders Meeting |
| 2025-06-23 | Press release | Serina Therapeutics to Present at FORCE Family Office Investor Webinar on June 26, 2025 |
| 2025-06-17 | Press release | UPDATED: Serina Therapeutics Congratulates Juvenescence Ltd. on $76M First Tranche Close of Series B Funding and Strateg |
| 2025-06-09 | Press release | Registration Is Now Open For Tribe Public’s CEO Presentation and Q&A Webinar Event "Is the Beaten Down Biotech Sector th |
| 2025-05-22 | Press release | Serina Therapeutics Appoints Stephen Brannan, M.D. to Board of Directors |
| 2025-05-14 | Press release | Serina Therapeutics Makes Grants to New Employees Under Inducement Plan |
| 2025-04-29 | Press release | Serina Therapeutics to Present at JonesResearch Virtual CNS Day |
| 2025-04-25 | Press release | Enable Injections Presents Survey Results Highlighting Missed Opportunities in Subcutaneous Oncology Drug Development at |
| 2025-04-15 | Press release | Serina Therapeutics to Present at the 4th LNP Formulation & Process Development Summit |
| 2025-04-08 | Press release | Serina Therapeutics Secures $5 Million in Funding to Support Advancement of SER-252 into Clinical Development in Advance |